Category News

Lilly’s EBGLYSS™ Achieves Skin Clearance and Itch Relief in Atopic Dermatitis Patients

Eli Lilly and Company has reported encouraging findings regarding its treatment EBGLYSS, showing significant improvements in skin condition and itch relief for patients suffering from moderate-to-severe atopic dermatitis (eczema) who had previously been treated with dupilumab. These results, stemming from…

Read MoreLilly’s EBGLYSS™ Achieves Skin Clearance and Itch Relief in Atopic Dermatitis Patients

PharmaJet Study: Tropis® Needle-Free System Boosts Polio Immunization Coverage and Cuts Costs

PharmaJet has announced compelling results from a groundbreaking implementation study in Nigeria, showing that their Tropis® ID Needle-free System significantly enhances polio immunization coverage, reduces costs, and gains widespread support among healthcare workers. The study, conducted with partners including Nigeria’s…

Read MorePharmaJet Study: Tropis® Needle-Free System Boosts Polio Immunization Coverage and Cuts Costs

Viz.ai Expands into Lung Disease to Accelerate Diagnosis and Care for Patients

Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, has announced expanded capabilities for its lung disease software. The new features incorporate natural language processing (NLP) alongside imaging AI to extract clinical insights from electronic health records (EHRs)…

Read MoreViz.ai Expands into Lung Disease to Accelerate Diagnosis and Care for Patients

Waltz Health and Noom Partner to Bring a Comprehensive and More Affordable Weight Loss Program to Employers

Waltz Health, a digital health company developing smarter, technology-enabled ways to price, distribute and prescribe medications and Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced a unique collaboration that…

Read MoreWaltz Health and Noom Partner to Bring a Comprehensive and More Affordable Weight Loss Program to Employers

VSee Health Expands Telehealth Services with New GLP-1 Program to Tackle Obesity and Chronic Disease

VSee Health, Inc. (Nasdaq: VSEE), a leading provider of telehealth services that optimize workflow and enhance patient care, has launched a new program to address obesity and related health risks by integrating GLP-1 prescription medications into its existing telehealth platform.…

Read MoreVSee Health Expands Telehealth Services with New GLP-1 Program to Tackle Obesity and Chronic Disease

Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round

Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the closing of an oversubscribed $225 million Series B financing round. The syndicate wasled by General…

Read MoreSeaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round

eClinicalWorks AI Tool Helps York Primary Care Save Over an Hour Daily on Fax Management

eClinicalWorks’ AI Technology Enables York Primary Care to Save Over an Hour Daily on Fax Management eClinicalWorks®, the largest ambulatory cloud EHR provider, has announced that York Primary Care is effectively utilizing its AI-powered EHR technology, including the innovative Image…

Read MoreeClinicalWorks AI Tool Helps York Primary Care Save Over an Hour Daily on Fax Management